Gerresheimer AG (FRA:GXI)
Market Cap | 966.43M |
Revenue (ttm) | 2.25B |
Net Income (ttm) | 23.35M |
Shares Out | n/a |
EPS (ttm) | 0.68 |
PE Ratio | 41.39 |
Forward PE | 7.54 |
Dividend | 0.04 (0.15%) |
Ex-Dividend Date | Jun 6, 2025 |
Volume | n/a |
Average Volume | 8,577 |
Open | 27.30 |
Previous Close | 27.48 |
Day's Range | 27.30 - 27.30 |
52-Week Range | 26.32 - 85.30 |
Beta | n/a |
RSI | 26.76 |
Earnings Date | Oct 10, 2025 |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery progra... [Read more]
Financial Performance
In 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.
Financial StatementsNews

EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: Gerresheimer AG / Preliminary announcement on the disclosure of financial statements Gerresheimer AG: Preliminary announcement of the publication of qua...

EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Gerresheimer AG / Preliminary announcement on the disclosure of financial statements Gerresheimer AG: Preliminary announcement of the publication of fin...

EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 14.10.2025 / 08:14 CET/CEST The issuer is solely responsi...

EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix ONYU*
EQS-News: Gerresheimer AG / Key word(s): Regulatory Approval Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix ONYU* 13.10.2025 / 10:00 CET/CEST The issuer is solely responsible for the conte...
Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives
Q3 2025 Gerresheimer AG Earnings Call Transcript
Q3 2025 Gerresheimer AG Earnings Call Transcript
Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMY) Q3 2025 Earnings Call October 9, 2025 2:30 AM EDTCompany ParticipantsGuido Pickert - Head of Investor RelationsDietmar...

Gerresheimer's shares fall 11% after another outlook cut
Shares in Gerresheimer fell 11% on Thursday, a day after the German packaging and medical equipment maker cut its 2025 guidance for the third time this year.

Gerresheimer Adjusts Guidance Amid Slower Market Growth
Gerresheimer AG revises its 2025 outlook amid slower market growth and underwhelming performance, initiating strategic changes to navigate challenges and prepare for future independence of its Moulded...

EQS-News: Gerresheimer: Business performance and slower market growth require guidance adjustment
EQS-News: Gerresheimer AG / Key word(s): Profit Warning/Quarter Results Gerresheimer: Business performance and slower market growth require guidance adjustment 08.10.2025 / 23:58 CET/CEST The issuer i...

Gerresheimer cuts 2025 outlook again as Q3 disappoints
German packaging and medical equipment maker Gerresheimer cut its 2025 guidance again on Wednesday, now expecting organic revenues to decline between 2-4% as third quarter results fell below expectati...

Gerresheimer: Adjusting 2025 Outlook Amid Slower Market Growth
Gerresheimer AG adjusts its 2025 forecast amid slower market growth, with Q3 revenues at EUR 560.7 million. A strategic transformation aims to counter a projected 2% to 4% revenue decline. Jetzt den v...

EQS-Adhoc: Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Profit Warning/Quarter Results Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025 08-Oct-2025 / 22:09 CET...

EQS-News: Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials
EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer Expands Wertheim Site with new Production Facility for Ready-to-fill Vials 01.10.2025 / 13:00 CET/CEST The issuer is solely responsible ...

EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...

EQS-News: Gerresheimer comments on the audit by German BaFin
EQS-News: Gerresheimer AG / Key word(s): Miscellaneous Gerresheimer comments on the audit by German BaFin 24.09.2025 / 10:48 CET/CEST The issuer is solely responsible for the content of this announcem...

Gerresheimer shares tank as financial regulator suspects accounting flaws
Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations.

Gerresheimer CFO resigns unexpectedly, successor to take over from September
Gerresheimer Chief Financial Officer Bernd Metzner has resigned from his role and will leave the company on August 31, the German packaging and medical equipment maker said on Friday.

EQS-News: Gerresheimer AG: Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025
EQS-News: Gerresheimer AG / Key word(s): Personnel Gerresheimer AG: Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025 29.08.2025 / 08:00 CET/CEST The issuer is solely respons...

EQS-News: Gerresheimer expands financial flexibility to implement growth strategy
EQS-News: Gerresheimer AG / Key word(s): Financing Gerresheimer expands financial flexibility to implement growth strategy 28.08.2025 / 09:30 CET/CEST The issuer is solely responsible for the content ...

Activist investor wants review at Gerresheimer after taking stake
Active Ownership, a major shareholder in Gerresheimer , said on Thursday it saw major potential for value creation at the German packaging and medical equipment specialist and called for a strategic r...

EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...

EQS-News: Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board
EQS-News: Gerresheimer AG / Key word(s): Personnel Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board 12.08.2025 / 08:00 CET/CEST The issuer is solely responsible for the content ...

Gerresheimer shares rise on plan to sell moulded glass business
Shares of German packaging and medical equipment maker Gerresheimer jumped around 4% in early trading on Tuesday after the company announced plans to sell its moulded glass business late on Monday.

Gerresheimer: Moulded Glass Spin-Off Sparks Sales Buzz
Gerresheimer AG is embarking on a transformative journey by divesting its thriving Moulded Glass business, a global leader with eight plants and impressive financial performance. In 2024, this powerho...